|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Selecta Biosciences, Inc. Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
8/31/2011 9:21:51 AM
WATERTOWN, Mass.--(BUSINESS WIRE)--Selecta Biosciences, Inc., a biopharmaceutical company developing novel targeted vaccines and immunotherapies, announced today that Takashi Kei Kishimoto, Ph.D., has been appointed as Chief Scientific Officer. Dr. Kishimoto brings more than 20 years of experience as a pharmaceutical and biotechnology scientist and leader. He will report directly to Werner Cautreels, Ph.D., Chief Executive Officer of Selecta Biosciences.
|
|
|
|
|
|
|
|
|
|
|